whi p154 and ag-490

whi p154 has been researched along with ag-490 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, DL; Ball, DJ; Beals, CR; Beckius, GE; Blumenkopf, TA; Borie, DC; Brissette, WH; Brown, MF; Casavant, JM; Changelian, PS; Conklyn, MJ; Des Etages, SG; Doty, JL; Elliott, EA; Finco-Kent, D; Fisher, DA; Fisher, MB; Flanagan, ME; Gaweco, AS; Hayes, LS; Higgins, J; Hines, M; Holm, B; Johnson, KS; Kawabata, TT; Kent, CR; Koslov, ER; Kudlacz, EM; Larson, M; Lillie, BM; Littman, BH; Magna, HA; Magnuson, KS; Martin, WH; McCurdy, SP; Milici, AJ; Morris, RE; Moyer, JD; Munchhof, MJ; Nelms, LF; O'Shea, JJ; Paniagua, R; Perry, BD; Reitz, B; Rizzuti, BJ; Saltarelli, MJ; Sawyer, PS; Shang-Poa, C; Si, MS; Smith, JF; Strelevitz, TJ; Su, C; Subramanyam, C; Sun, J; Whipple, DA; Woodworth, TG; Yoon, K; Zagouras, P; Zhou, YJ1
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A1
Kankaanranta, H; Kärpänniemi, O; Korhonen, R; Moilanen, E; Nieminen, R; Sareila, O1
Baik, EJ; Chung, JI; Jung, YS; Kim, YH; Lee, SH; Moon, CH; Suh-Kim, H; Woo, HG1

Other Studies

4 other study(ies) available for whi p154 and ag-490

ArticleYear
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.
    Science (New York, N.Y.), 2003, Oct-31, Volume: 302, Issue:5646

    Topics: Animals; Enzyme Inhibitors; Gene Expression Regulation; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Interleukin-2; Janus Kinase 3; Kidney Transplantation; Lymphocyte Activation; Lymphocyte Count; Lymphocyte Culture Test, Mixed; Lymphocyte Subsets; Macaca fascicularis; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Myocardium; Piperidines; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Transplantation, Heterotopic; Transplantation, Homologous; Tumor Cells, Cultured

2003
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2

    Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase

2013
JAK inhibitors AG-490 and WHI-P154 decrease IFN-gamma-induced iNOS expression and NO production in macrophages.
    Mediators of inflammation, 2006, Volume: 2006, Issue:2

    Topics: Animals; Blotting, Western; Cell Nucleus; Enzyme Inhibitors; Interferon-gamma; Interferon-Stimulated Gene Factor 3; Janus Kinase 1; Macrophages; Mice; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Polymerase Chain Reaction; Quinazolines; Tyrphostins

2006
Differential regulation of proliferation and differentiation in neural precursor cells by the Jak pathway.
    Stem cells (Dayton, Ohio), 2010, Volume: 28, Issue:10

    Topics: Animals; Blotting, Western; Brain; Cell Differentiation; Cell Proliferation; Cells, Cultured; Immunohistochemistry; Janus Kinase 2; Janus Kinase 3; Mice; Neurogenesis; Neurons; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Stem Cells; Tyrphostins

2010